Dr. Elisha Singer, MD

Dr. Singer practices at Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic.

Dr. Singer's NPI, 1730523093, was assigned on April 17, 2013. Dr. Singer graduated from Perelman School of Medicine - Philadelphia in 2013. Dr. Singer holds Florida license ME153527.

Dr. Singer's primary practice is Mayo Clinic Hospital, at 4500 San Pablo Rd, Jacksonville, FL 32224 in Duval County. The practice phone is (904) 953-2000.

Dr. Singer's primary practice is Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic. The medical group on file is Mayo Clinic Jacksonville. Dmand AI also links Dr. Singer to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Singer practices. Vendor and product names are available with a free account.

Dermatology is Dr. Singer's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Singer is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Singer's licenses on file in 4 states: Florida, New York, New Jersey and Illinois.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, corns and calluses, hives, itchy rashes and joint cyst among the conditions Dr. Singer treats.

CMS data shows 2,111 Medicare services from Dr. Singer across 15 procedure codes in 2024, for 722 Medicare patients. Medicare paid $109,427 for them. Every service was in an office.

CMS counts 722 Medicare patients who saw Dr. Singer in 2024. The largest group is 65 to 74, with 344 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Singer's median patient age at 60, with 46% women.

In 2024, Dr. Singer wrote 762 Medicare Part D claims for 326 patients. 90% of them were for generic drugs. CMS names the drug for 506 of them, across 16 drugs with 11 or more claims each, at $74,343 in total drug cost. In 2023, CMS named 1,394 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Singer for performance year 2024, reported through an alternative payment model (APM). Dr. Singer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Singer as offering telehealth. CMS counts 363 procedures of skin biopsy by Dr. Singer, more than 93% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Singer in 2025. Dr. Singer has published most often in Am J Dermatopathol. Dr. Singer's most frequent co-authors are Olayemi Sokumbi, MD and Jason C. Sluzevich, MD.

CMS Open Payments shows 25 general payments to Dr. Singer from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Abbvie Inc. paid the most, $597.

Dr. Singer graduated from Perelman School of Medicine - Philadelphia in 2013.

Dr. Singer is in network with 9 carriers, including Excellus BlueCross BlueShield, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.